A pharmacologic overview of current and emerging anticoagulants

Article Type
Changed
Tue, 09/25/2018 - 11:04
Display Headline
A pharmacologic overview of current and emerging anticoagulants
Article PDF
Author and Disclosure Information

Edith A. Nutescu, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Nancy L. Shapiro, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Aimee Chevalier, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Alpesh N. Amin, MD, MBA
Department of Medicine, University of California, Irvine

Correspondence: Edith A. Nutescu, PharmD, University of Illinois at Chicago, College of Pharmacy, 833 S. Wood Street, MC 886, Chicago, IL 60612; enutescu@uic.edu

Dr. Nutescu has received grant/research support from AstraZeneca and is a consultant for Sanofi-Aventis and GlaxoSmithKline.

Drs. Shapiro and Chevalier have indicated that they have nothing to disclose.

Dr. Amin is on the speakers' bureau of Sanofi-Aventis.

Publications
Page Number
S2-S6
Author and Disclosure Information

Edith A. Nutescu, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Nancy L. Shapiro, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Aimee Chevalier, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Alpesh N. Amin, MD, MBA
Department of Medicine, University of California, Irvine

Correspondence: Edith A. Nutescu, PharmD, University of Illinois at Chicago, College of Pharmacy, 833 S. Wood Street, MC 886, Chicago, IL 60612; enutescu@uic.edu

Dr. Nutescu has received grant/research support from AstraZeneca and is a consultant for Sanofi-Aventis and GlaxoSmithKline.

Drs. Shapiro and Chevalier have indicated that they have nothing to disclose.

Dr. Amin is on the speakers' bureau of Sanofi-Aventis.

Author and Disclosure Information

Edith A. Nutescu, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Nancy L. Shapiro, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Aimee Chevalier, PharmD
Department of Pharmacy Practice and the Antithrombosis Service, College of Pharmacy, University of Illinois at Chicago

Alpesh N. Amin, MD, MBA
Department of Medicine, University of California, Irvine

Correspondence: Edith A. Nutescu, PharmD, University of Illinois at Chicago, College of Pharmacy, 833 S. Wood Street, MC 886, Chicago, IL 60612; enutescu@uic.edu

Dr. Nutescu has received grant/research support from AstraZeneca and is a consultant for Sanofi-Aventis and GlaxoSmithKline.

Drs. Shapiro and Chevalier have indicated that they have nothing to disclose.

Dr. Amin is on the speakers' bureau of Sanofi-Aventis.

Article PDF
Article PDF
Page Number
S2-S6
Page Number
S2-S6
Publications
Publications
Article Type
Display Headline
A pharmacologic overview of current and emerging anticoagulants
Display Headline
A pharmacologic overview of current and emerging anticoagulants
Citation Override
Cleveland Clinic Journal of Medicine 2005 April;72(suppl 1):S2-S6
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media